Morbus Parkinson - Mehr Lebensqualität

Literatur

• 01 Movement Disorder Society of Australia Clinical Research & Trial Group and QUEST-AP Study Group. A randomized, double-blind study to compare the effect on quality of life of levodopa/carbidopa/entacapone (Stalevo®) with levodopa/carbidopa in patients with Parkinson's disease with no or minimal, non disabling motor fluctuations. Poster präsentiert auf dem Movement Disorder Society's 10th International Congress of Parkinson's Disease and Movement Disorders in Kyoto. 2006
• 02 Myllylä V . et al . Patient satisfaction with switching to Stalevo: an open-label evaluation in PD patients experiencing wearing-off (Simcom Study).  Acta Neurol Scand. 2006;  114 (3) 181-186
• 03 Olanow CW . et al . Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease.  Arch Neurol. 2004;  61 (10) 1563-1568